Increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages associate with poor clinical outcomes in BCG treated non-muscle invasive bladder cancer
B. Ravenscroft, P. Yolmo, S. Chenard, S. Rahimi, K. Pace, K. Sachdeva, T. Jamaspishvilli, H. Ghadei, A. Garven, K. Tyryshkin, D. M. Berman, C. Jackson, D. R. Siemens, M. Koti
This study identifies increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages as predictors of poor clinical outcomes in BCG-treated NMIBC patients.
bioRxiv · Oct 19, 2023 · PreprintCancer Biology